- Home
- HYLN vs NBP Comparison
HYLN vs NBP Comparison
Compare HYLN & NBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HYLN | NBP |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | United States |
| Employees | N/A | 30 |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 328.1M | 275.2M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | HYLN | NBP |
|---|---|---|
| Price | $2.12 | $2.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $5.00 | ★ $9.00 |
| AVG Volume (30 Days) | 694.8K | ★ 1.0M |
| Earning Date | 05-12-2026 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,475,000.00 | N/A |
| Revenue This Year | $197.93 | N/A |
| Revenue Next Year | $301.97 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 130.28 | N/A |
| 52 Week Low | $1.11 | $2.10 |
| 52 Week High | $2.56 | $5.19 |
Technical Indicators
Market Signals| Indicator | HYLN | NBP |
|---|---|---|
| Relative Strength Index (RSI) | 64.50 | 42.02 |
| Support Level | $1.80 | $2.27 |
| Resistance Level | $2.22 | $2.78 |
| Average True Range (ATR) | 0.10 | 0.14 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 83.53 | 21.05 |
Price Performance
Historical ComparisonAbout HYLN Hyliion Holdings Corp.
Hyliion Holdings Corp designs and develops power generators for stationary and mobile applications and provides R&D service. It provides solutions that enable clean, flexible, and affordable electricity production. The company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies. Its products and services include: KARNO Power Modules which is a modular, fully enclosed, fuel-agnostic and fully integrated power generating solution.
About NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.